Cargando…
Methylation mediated silencing of TMS1/ASC gene in prostate cancer
BACKGROUND: Transcriptional silencing associated with aberrant promoter methylation has been established as an alternate pathway for the development of cancer by inactivating tumor suppressor genes. TMS1 (Target of Methylation induced Silencing), also known as ASC (Apoptosis Speck like protein conta...
Autores principales: | Das, Partha M, Ramachandran, Kavitha, VanWert, Jane, Ferdinand, Larry, Gopisetty, Gopal, Reis, Isildinha M, Singal, Rakesh |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1543653/ https://www.ncbi.nlm.nih.gov/pubmed/16848908 http://dx.doi.org/10.1186/1476-4598-5-28 |
Ejemplares similares
-
CpG island methylation of TMS1/ASC and CASP8 genes in cervical cancer
por: Tamandani, DM Kordi, et al.
Publicado: (2009) -
Silencing of ASC in Cutaneous Squamous Cell Carcinoma
por: Meier, Katharina, et al.
Publicado: (2016) -
Correlation between promoter methylation of p14(ARF), TMS1/ASC, and DAPK, and p53 mutation with prognosis in cholangiocarcinoma
por: Xiaofang, Liu, et al.
Publicado: (2012) -
Pederin, Psymberin and the Structurally Related Mycalamides: Synthetic Aspects and Biological Activities
por: Witczak, Zbigniew J., et al.
Publicado: (2014) -
Serum GADD45a methylation is a useful biomarker to distinguish benign vs malignant prostate disease
por: Reis, I M, et al.
Publicado: (2015)